• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    K2M Group Reports Fourth Quarter and Full Year 2017 Financial Results

    Written by Gabrielle Lakusta
    |
    Mar. 01, 2018 09:26AM PST

    K2M Group (Nasdaq:KTWO) a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today reported financial results for its fourth quarter and fiscal year ended December 31, 2017. As quoted in the press release: Total fiscal year 2017 revenue of $258.0 million, up 9% year-over-year on both a …

    K2M Group (Nasdaq:KTWO) a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today reported financial results for its fourth quarter and fiscal year ended December 31, 2017.

    As quoted in the press release:

    • Total fiscal year 2017 revenue of $258.0 million, up 9% year-over-year on both a reported basis and on a constant currency basis.
    • Domestic fiscal year 2017 revenue of $197.3 million, up 9% year-over-year, comprised of:
      • U.S. Complex Spine growth of 8% year-over-year
      • U.S. Minimally Invasive Surgery (MIS) growth of 16% year-over-year
      • U.S. Degenerative growth of 8% year-over-year
    • International fiscal year 2017 revenue of $60.7 million, up 9% year-over-year, or 10% on a constant currency basis.

    Click here to read the full press release.

    financial resultsmedical device investing
    The Conversation (0)

    Go Deeper

    AI Powered

    Misonix Reports Record Second Quarter Revenue

    Fourth Quarter Financial Results Announced by Materialise

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cleo Diagnostics

    Cleo Diagnostics (COV:AU)
    COV:AU

    Ocumetics Technology

    Ocumetics Technology (OTC:CC)
    OTC:CC

    Premier Health of America

    Premier Health of America (PHA:CC)
    PHA:CC

    Bloom Health Partners

    Bloom Health Partners (BLMH:CC)
    BLMH:CC

    Avricore Health

    Avricore Health (AVCR:CC)
    AVCR:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES